SCHEMBL8094917

SCHEMBL8094917

CS(=O)(=O)NSc1ccccc1C(=O)Nc1ccc(Cl)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 1/20 0.52
CA1 P00915 1/20 0.50
CA2 P00918 1/20 0.50
CA9 Q16790 1/20 0.50
SMN1; SMN2 Q16637 5/20 0.48
KMT2A Q03164 4/20 0.48
MEN1 O00255 3/20 0.48
ALDH1A1 P00352 3/20 0.48
HTT P42858 2/20 0.48
KDM4E B2RXH2 1/20 0.48
HPGD P15428 1/20 0.48
RAB9A P51151 5/20 0.47
NPC1 O15118 4/20 0.47
MAPT P10636 3/20 0.47
PNLIP P16233 1/20 0.47
AVPR2 P30518 1/20 0.46
GPR27 Q9NS67 1/20 0.46
GAA P10253 1/20 0.46
LMNA P02545 1/20 0.46
BCAT2 O15382 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8622864 0.80 SMN1; SMN2 (0.69) KDRSMN1; SMN2KMT2AMEN1ALDH1A1
SCHEMBL8094954 0.77 KMT2A (0.78) SMN1; SMN2KMT2AMEN1ALDH1A1HTT
SCHEMBL8094921 0.76 MAPT (0.56) CA1CA9SMN1; SMN2KMT2AMEN1
SCHEMBL11440099 0.74 KDR (0.55) KDRCA1CA2CA9SMN1; SMN2
SCHEMBL8665327 0.72 CA1 (0.74) CA1CA2CA9SMN1; SMN2KMT2A
SCHEMBL2119568 0.72 HPGD (0.74) KDRSMN1; SMN2KMT2AMEN1ALDH1A1
SCHEMBL2117583 0.72 SMO (0.75) SMN1; SMN2KMT2AMEN1HPGDRAB9A
SCHEMBL7820643 0.70 ALDH1A1 (0.76) KMT2AMEN1ALDH1A1MAPTPNLIP
SCHEMBL2698725 0.70 PNLIP (0.82) SMN1; SMN2KMT2AMEN1ALDH1A1HTT
SCHEMBL1961988 0.69 FADS1 (0.73) KMT2AMEN1ALDH1A1HTTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6147115-A SULFONYLUREIDO-4-HALOBENZENE DERIVATIVES; ANTICARCINOGENIC AGENTS ELI LILLY AND COMPANY (US) 2000-11-14 US claimed
EP-0467621-B1 N-phenyl-N'-alkylsulfonylureas, process for their preparation and antitumor compositions containing them LILLY CO ELI (US) 1994-06-15 EP claimed
EP-0467621-A1 N-phenyl-N'-alkylsulfonylureas, process for their preparation and antitumor compositions containing them ELI LILLY AND COMPANY (US) 1992-01-22 EP claimed
US-6147115-A SULFONYLUREIDO-4-HALOBENZENE DERIVATIVES; ANTICARCINOGENIC AGENTS ELI LILLY AND COMPANY (US) 2000-11-14 US disclosed
EP-0467621-B1 N-phenyl-N'-alkylsulfonylureas, process for their preparation and antitumor compositions containing them LILLY CO ELI (US) 1994-06-15 EP disclosed
US-5216026-A Administering to the mammal N-1-butanesulfonamide derivatives and salts ELI LILLY AND COMPANY (US) 1993-06-01 US disclosed
EP-0467621-A1 N-phenyl-N'-alkylsulfonylureas, process for their preparation and antitumor compositions containing them ELI LILLY AND COMPANY (US) 1992-01-22 EP disclosed